Skip to main content
. 2020 Mar 31;34(3):303–310. doi: 10.1007/s10557-020-06972-4

Fig. 2.

Fig. 2

Infarct size measurement. a Histogram shows the infarct size of controls, ramelteon, and 4P-PDOT—with and without ramelteon. b Histogram shows the infarct size of controls, ramelteon, MPG, and CsA administered at two different time points. Data are presented as means ± SD, *P < 0.05 vs. Con, #P < 0.05 vs. Ram, §P < 0.05 vs. MPG+Ram. Con, control; Ram, ramelteon; 4P-PDOT, 4-phenyl-2-propionamidotetralin; MPG, N-2-mercaptopropionylglycine; CsA, cyclosporine A